arrow
M

Maria Chiara Tronconi

irccs- humanitas research hospital
H指数:21
被引数:2,170

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events

免疫检查点抑制剂治疗患者中心脏不良事件的MRI研究:一项前瞻性队列研究

2025-03-180
OA
Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis
2024-06-010
PRE
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023-07-015
PRE
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival
2020-09-1518
OAAI
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

Tivantinib和西妥昔单抗在KRAS野生型转移性结直肠癌患者中对EGFR抑制剂获得性耐药和MET过表达的出现的II期研究: 未来EGFR/MET双重抑制试验的经验教训

2019-06-0142
PREAI
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study
2015-09-0111
PREAI
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
2015-03-0190
OAAI